Recent Stories
Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: RobotsBlack October Wasn't an Attack Wave. It Was a Warning.Extreme Ownership Means Ultimate Achievement – NASA Culture Shift

The Wave

← Back to the board
Issue file · proposed

NIH/NIAID viral hemorrhagic fever vaccine development funding (filovirus and Lassa fever)

Federal funding and contracting for advanced development of vaccines against filoviruses (Ebola, Marburg) and Lassa fever, including NIAID contract awards to universities and industry, biodefense and pandemic preparedness appropriations, and the impact of NIH budget and policy changes on countermeasure pipelines.

Biotech
Earliest seen
—
No coverage yet
Articles · 30d
0
No coverage
Outlets
0
—
Hill · 30d
0
None in 30 days or ahead
Contracts · 30d
0
No awards or solicitations
Momentum
0.0
Articles ±0 vs prior week

Activity

30 days back, 14 ahead · hollow = scheduled
Total
0
Peak/day
0
7d
0±0
Next
—
Σ/day0
Hill0
Contracts0
News0

What's happening

No summary yet: this issue is new.

Hill

No policymaker activity in the window.

Contracts

No procurement or funding activity in the window.

Pressure

No outside pressure in the window.

Who covered it, when

A dot per article · ringed = earliest in our sources

No coverage in the last 30 days.

In the news

0 articles

No coverage yet.

The Wave Terminal · from the 0 outlets we follow on this issue

Cookies

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy

NIH/NIAID viral hemorrhagic fever vaccine development funding (filovirus and Lassa fever) — The Wave